Submitted by Anonymous (not verified) on 17 June 2025 - 14:22
Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 22, Status: Authorised